Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

The Effect of GDP and Distance on Timing of COVID-19 Spread in Chinese Provinces in 2020

Alice Kuan, Mingxin Chen, David Bishai
doi: https://doi.org/10.1101/2020.07.19.20157354
Alice Kuan
1Johns Hopkins University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mingxin Chen
2Johns Hopkins Bloomberg School of Public Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Bishai
2Johns Hopkins Bloomberg School of Public Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: dbishai1@jhu.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

The geographical spread of COVID-19 across China’s provinces provides the opportunity for retrospective analysis on contributors to the timing of the spread. Highly contagious diseases need to be seeded into populations and we hypothesized that greater distance from the epicenter in Wuhan, as well as higher province-level GDP per capita, would delay the time until a province detected COVID-19 cases. To test this hypothesis, we used province-level socioeconomic data such as GDP per capita and percentage of the population aged over 65, distance from the Wuhan epicenter, and health systems capacity in a Cox proportional hazards analysis of the determinants of each province’s time until epidemic start. The start was defined by the number of days it took for each province to reach thresholds of 3, 5, 10, or 100 cases. We controlled for the number of hospital beds and physicians as these could influence the speed of case detection. Surprisingly, none of the explanatory variables had a statistically significant effect on the time it took for each province to get its first cases; the timing of COVID-19 spread appears to have been random with respect to distance, GDP, demography, and the strength of the health system. Looking to other factors, such as travel, policy, and lockdown measures, could provide additional insights on realizing most critical factors in the timing of spread.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No funding received for this project.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This is not human subjects research, so IRB approval was not needed.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Methods section updated to clarify model.

  • 1 Number of Provinces indicates how many provinces were included in the analysis for each threshold; in other words, how many provinces had not yet reached the threshold on Jan 22 nd, 2020. There are 31 provinces in total. The number of provinces that had already reached or surpassed the threshold by that day are thus 22, 17, 5, and 1 respectively in order of the columns from left to right.

Data Availability

The data on cumulative COVID-19 cases in Chinese provinces is publicly available from the JHU CSSE Github repository. Data on province-level variables is available from Beijing University.

https://github.com/CSSEGISandData/COVID-19

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted February 09, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
The Effect of GDP and Distance on Timing of COVID-19 Spread in Chinese Provinces in 2020
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The Effect of GDP and Distance on Timing of COVID-19 Spread in Chinese Provinces in 2020
Alice Kuan, Mingxin Chen, David Bishai
medRxiv 2020.07.19.20157354; doi: https://doi.org/10.1101/2020.07.19.20157354
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
The Effect of GDP and Distance on Timing of COVID-19 Spread in Chinese Provinces in 2020
Alice Kuan, Mingxin Chen, David Bishai
medRxiv 2020.07.19.20157354; doi: https://doi.org/10.1101/2020.07.19.20157354

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Health Economics
Subject Areas
All Articles
  • Addiction Medicine (76)
  • Allergy and Immunology (202)
  • Anesthesia (55)
  • Cardiovascular Medicine (495)
  • Dentistry and Oral Medicine (91)
  • Dermatology (57)
  • Emergency Medicine (170)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (217)
  • Epidemiology (5749)
  • Forensic Medicine (3)
  • Gastroenterology (221)
  • Genetic and Genomic Medicine (883)
  • Geriatric Medicine (89)
  • Health Economics (233)
  • Health Informatics (777)
  • Health Policy (400)
  • Health Systems and Quality Improvement (256)
  • Hematology (105)
  • HIV/AIDS (187)
  • Infectious Diseases (except HIV/AIDS) (6581)
  • Intensive Care and Critical Care Medicine (397)
  • Medical Education (119)
  • Medical Ethics (28)
  • Nephrology (94)
  • Neurology (859)
  • Nursing (45)
  • Nutrition (143)
  • Obstetrics and Gynecology (166)
  • Occupational and Environmental Health (266)
  • Oncology (521)
  • Ophthalmology (168)
  • Orthopedics (44)
  • Otolaryngology (107)
  • Pain Medicine (48)
  • Palliative Medicine (22)
  • Pathology (150)
  • Pediatrics (257)
  • Pharmacology and Therapeutics (147)
  • Primary Care Research (116)
  • Psychiatry and Clinical Psychology (990)
  • Public and Global Health (2264)
  • Radiology and Imaging (380)
  • Rehabilitation Medicine and Physical Therapy (175)
  • Respiratory Medicine (314)
  • Rheumatology (110)
  • Sexual and Reproductive Health (83)
  • Sports Medicine (83)
  • Surgery (118)
  • Toxicology (25)
  • Transplantation (34)
  • Urology (42)